You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一心堂(002727.SZ):擬與工投集團共設雲醫藥 利於拓展智慧化專業處方藥房及慢病管理業務
格隆匯 03-19 16:18

格隆匯3月19日丨一心堂(002727.SZ)公佈,公司主營業務為藥品零售連鎖,全面轉型大健康藥店以來,公司始終以健康類產品經營為核心,致力於為廣大民眾提供專業、全面的健康解決方案。在全面發展上述業務的同時,公司正積極拓展面對醫療機構的處方藥品、醫療器械、醫療耗材等銷售業務和智慧診療業務,構建全面的大健康產業鏈。

為滿足公司戰略發展的需要,公司、公司控股子公司雲南鴻雲醫藥投資有限公司(“鴻雲投資”)擬與雲南省工業投資控股集團有限責任公司(“工投集團”)共同出資設立雲醫藥股份有限公司(具體名稱以主管機關核定為準)進一步實施拓展公司業務,保障公司進一步實施拓展公司業務,保障公司未來的產業戰略順利實施。

雲醫藥股份有限公司(具體名稱以主管機關核定為準),註冊資本:5000萬元,經營範圍:中成藥、中藥飲片、生化藥品、化學藥製劑、抗生素、生物製品(含血液製品、不含疫苗)、預包裝食品、乳製品(含嬰幼兒配方乳粉)、保健食品、醫療器械、中西醫科診療、健康信息諮詢、商務信息諮詢醫藥技術研究、開發及技術諮詢等(依法需經批准的項目,經相關部門批准後方可開展經營活動)(具體內容以主管機關核定為準)

此次投資有利於公司拓展智慧化專業處方藥房及慢病管理業務,為公司創造良好的經濟效益,符合公司和股東利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account